Compare FDBC & TMCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FDBC | TMCI |
|---|---|---|
| Founded | 1902 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 319.9M | 292.0M |
| IPO Year | 2000 | 2021 |
| Metric | FDBC | TMCI |
|---|---|---|
| Price | $68.42 | $3.95 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $5.50 |
| AVG Volume (30 Days) | 10.5K | ★ 190.1K |
| Earning Date | 10-21-2026 | 11-06-2026 |
| Dividend Yield | ★ 2.70% | N/A |
| EPS Growth | ★ 35.00 | N/A |
| EPS | ★ 2.63 | N/A |
| Revenue | N/A | ★ $212,690,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $6.88 |
| P/E Ratio | $26.64 | ★ N/A |
| Revenue Growth | N/A | ★ 1.59 |
| 52 Week Low | $41.00 | $1.17 |
| 52 Week High | $71.96 | $5.25 |
| Indicator | FDBC | TMCI |
|---|---|---|
| Relative Strength Index (RSI) | 69.22 | 40.91 |
| Support Level | $53.13 | $3.82 |
| Resistance Level | N/A | $4.77 |
| Average True Range (ATR) | 2.21 | 0.38 |
| MACD | 0.45 | -0.03 |
| Stochastic Oscillator | 71.55 | 25.96 |
Fidelity D & D Bancorp Inc is a bank holding company. Through its wholly-owned state chartered commercial bank subsidiary, The Fidelity Deposit and Discount Bank (the Bank), the company provides a full range of banking, trust and financial services to individuals, small businesses and corporate customers. Its primary market areas are Lackawanna, Luzerne and Northampton Counties, Pennsylvania. The company's primary deposit products are demand deposits and interest-bearing time, money market and savings accounts. The company's segments include: Commercial and Industrial, Commercial Real Estate, Consumer, Residential Real Estate, with the majority of revenue generating from the Commercial Real Estate segment.
Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The company operates and manages its business as a single segment: designing, manufacturing, and marketing medical devices for surgeons, ambulatory surgery centers, and hospitals related to the surgical management of bunion and related midfoot deformities.